Home / Import refusals / AEK-7725026-1/21/1

AEK-7725026-1/21/1

Glenmark Pharmaceuticals Limited — FEI 3008565058

Recent inspections

  • 1122868 (NAI Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1107098 (NAI Fri Sep 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1053034 (VAI Thu May 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1028538 (NAI Sat Aug 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 962557 (VAI Fri Feb 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

Compliance actions

Other import refusals

  • AEK-9274924-9/90003/1 (Tue Feb 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9409404-0/100003/1 (Fri Feb 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-0770066-3/20003/1 (Fri Jan 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Devices)
  • 799-0358947-4/130003/1 (Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-9624690-8/20003/1 (Fri Dec 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

Refusal Details

Date
August 24, 2020
Country
India
Product Category
Drugs and Biologics
Product Code
62ODA14 AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II)
Charges
75